4.5 Article

An inherited variant in the gene coding for vitamin D-binding protein and survival from cutaneous melanoma: a BioGenoMEL study

Journal

PIGMENT CELL & MELANOMA RESEARCH
Volume 27, Issue 2, Pages -

Publisher

WILEY
DOI: 10.1111/pcmr.12193

Keywords

vitamin D; melanoma; survival analysis; mendelian randomization; GC

Funding

  1. Skin Cancer Research Fund (SCaRF)
  2. Yorkshire Cancer Research (YCR)
  3. World Universities Net- work/University of Leeds International Matched Partnership Fund award
  4. European Commission [LSHC-CT-2006-018702]
  5. National Cancer Institute (NCI) of the US National Institute of Health (NIH) [CA83115]
  6. Cancer Research UK [C8216/A6129, C588/A4994, C588/A10589, C37059/A11941]
  7. Swedish Cancer Society
  8. Radiumhemmet Research Funds
  9. Karolinska Institutet Research Funds
  10. Latvian Council of Science: ESF Project [1DP/1.1.1.2.0/09/APIA/VIAA/150, 10.0010.8]
  11. European Biobanking and Biomolecular Resources Research Infrastructure (BBMRI)-Netherlands hub [CO18]
  12. DFG [Scha 422/11-1]
  13. Osterreichische National-bank [12161, 13036]
  14. Hans und Blanca Moser Stiftung
  15. Fondo de Investigaciones Sanitarias [05/0302, 06/0265, 09/1393, 12/00840]
  16. Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)
  17. Swedish Research Council
  18. Gunnar Nilsson Foundation
  19. Berta Kamprad Foundation
  20. European Research Council [ERC-2011-294576]
  21. Cancer Research UK [10589] Funding Source: researchfish

Ask authors/readers for more resources

An association between low serum vitamin D levels and poorer melanoma survival has been reported. We have studied inheritance of a polymorphism of the GC gene, rs2282679, coding for the vitamin D-binding protein, which is associated with lower serum levels of vitamin D, in a meta-analysis of 3137 melanoma patients. The aim was to investigate evidence for a causal relationship between vitamin D and outcome (Mendelian randomization). The variant was not associated with reduced overall survival (OS) in the UK cohort, per-allele hazard ratio (HR) for death 1.23 (95% confidence interval (CI) 0.93, 1.64). In the smaller cohorts, HR in OS analysis was 1.07 (95% CI 0.88, 1.3) and for all cohorts combined, HR for OS was 1.09 (95% CI 0.93, 1.29). There was evidence of increased melanoma-specific deaths in the seven cohorts for which these data were available. The lack of unequivocal findings despite the large sample size illustrates the difficulties of implementing Mendelian randomization.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available